FindMyKOL

Abby Rosenberg, MD

Enriched profile

Director, Pediatric Palliative Care · Boston Children's Hospital

ORCID↗NPI↗
✓ Itemized profile
Region🇺🇸 Boston, MA · Northeast · United StatesSpecialtyHematology / OncologyFocusHealth Systems, Economic Evaluations, Quality of Life+4
Active KOLFindMyKOL type: RegionalLatest publication2021Online presenceNone verifiedPayments2023–2023NIH funding2022–2026

Abby Rosenberg is Director, Pediatric Palliative Care at Boston Children's Hospital. OpenAlex indexes 10 publications with 224 citations (h-index 6); ClinicalTrials.gov lists 4 registered studies with this person as an investigator.

Data verified 27 Oct 2026

Overview

Updated 31 Oct 2026

Abby R. Rosenberg is Director, Pediatric Palliative Care at Boston Children's Hospital. The public record shows 10 publications with 224 citations (h-index 6), centered on Health Systems, Economic Evaluations, Quality of Life, Nonmelanoma Skin Cancer Studies, Cutaneous lymphoproliferative disorders research. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 1 companies, 5 NIH-funded awards (2022–2026).

  • Most recent indexed publication: 2021 · The British journal of dermatology
  • Top research focus: Health Systems, Economic Evaluations, Quality of Life
  • 4 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 1 companies

Generated from the cited public record · current as of 31 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Depression (MDD)2 trialsLeukemia (AML/ALL/CML/CLL)1 trialLymphoma1 trialNeuro-Oncology / Glioma1 trialSarcoma1 trialLeukemia, Myeloid, Acute1 trialPrecursor Cell Lymphoblastic Leukemia-Lymphoma1 trialBrain Neoplasms1 trialComa1 trialNeoplasms, Germ Cell and Embryonal1 trialBone Marrow Neoplasms1 trialMelanoma

Research focus

OpenAlex concept fingerprint
Health Systems, Economic Evaluations, Quality of LifeNonmelanoma Skin Cancer StudiesCutaneous lymphoproliferative disorders researchCancer survivorship and careCutaneous Melanoma Detection and Management

Works with

trial sponsors and companies reporting payments
Dana-Farber Cancer InstituteClinical trials2Industry payments—Seattle Children's HospitalClinical trials2Industry payments—GlaxoSmithKline, LLC.Clinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
10publications

Distinct works indexed by OpenAlex, matched via ORCID; 2 in PubMed.

224citations

Total citations across indexed works.

6h-index

Hirsch index (OpenAlex). i10-index 4.

Clinical & industry

trials, payments and federal funding
4clinical trials

Investigator role on registered studies.

View trials ↓
1companies · 2023–2023

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
5NIH grants · 2022–2026

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 31 Oct 2026

Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:

All 4 trial records: search, sort and filter.Explore →

Industry payments

Updated 31 Oct 2026

1 company reported payments to CMS in program years 2023–2023. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

NIH funding

Updated 31 Oct 2026

5 NIH research awards on record, funded 2022–2026 per NIH RePORTER. The latest:

All 28 award records: search, sort and filter.Explore →

Publications

Updated 31 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Most-cited works

by citation count (OpenAlex)
  1. 01
    Skin cancer precursor immunotherapy for squamous cell carcinoma prevention
    Article107 citations2019
    doi.org ↗
  2. 02
    Health‐related quality of life and economic implications of cutaneous T‐cell lymphoma
    Article35 citations2019
    doi.org ↗
  3. 03
    Clinical severity measures and quality‐of‐life burden in patients with mycosis fungoides and Sézary syndrome: comparison of generic and dermatology‐specific instruments
    Article34 citations2019
    doi.org ↗
  4. 04
    Current measures are not sufficient: an interview‐based qualitative assessment of quality of life in cutaneous T‐cell lymphoma*
    Article28 citations2020
    doi.org ↗
  5. 05
    Patient Concerns About Nasal Reconstruction After Mohs Surgery and Implications for Shared Decision Making
    Article8 citations2018
    doi.org ↗
All 10 cited works: search, sort and filter.Explore →

Network

Updated 31 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Yevgeniy R. Semenov7Amy C. M. Musiek5Christina M. Herbosa5Neha Mehta–Shah5Lynn A. Cornelius3Sara J. Weston2Shadmehr Demehri2Kenneth H. Ngo2Teresa L. Deshields2Michael Wallendorf2Gerald P. Linette2Ilana S. Rosman2Ryan Courtney Fields2Mary Tabacchi2Sara Kukuljan1Donna B. Jeffe1Dorina Kallogjeri1Jay F. Piccirillo1Mary C. Politi1Omolade O. Sogade1Lynn A. Cornelius1Samuel Hahn1Trisha S. Bhat1

Background & recognition

Updated 31 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Awards & honors

honors on the public record

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.